Sequential anthracycline and weekly paclitaxel might be more effective compared to docetaxel and cyclophosphamide in the adjuvant treatment of HER2-negative breast cancer patients.

Authors :: Altundag K
Source :: Journal of B.U.ON. : official journal of the Balkan Union of Oncology [J BUON] 2021 May-Jun; Vol. 26 (3), pp. 1172.
Publication Year :: 2021

Subjects :: Chemotherapy, Adjuvant
Drug Therapy, Combination
Female
Humans
Receptor, ErbB-2
Treatment Outcome
Anthracyclines administration & dosage
Antineoplastic Agents administration & dosage
Antineoplastic Combined Chemotherapy Protocols therapeutic use
Breast Neoplasms drug therapy
Cyclophosphamide administration & dosage
Docetaxel administration & dosage

Language :: English
ISSN :: 2241-6293
Volume :: 26
Issue :: 3
Database :: MEDLINE
Journal :: Journal of B.U.ON. : official journal of the Balkan Union of Oncology
Publication Type :: Editorial & Opinion
Accession number :: 34268990

Tools